Advanced Search

Primary Care Coding Alert

Reader Question:

Injection Coding

Published on Fri Dec 01, 2000

Question: Is it allowable for us to bill 90782 (therapeutic, prophylactic or diagnostic injection [specify material injected]; subcutaneous or intramuscular), along with a J code such as J1100 (injection, dexamethosone sodium phosphate, up to 4 mg/ml)?

Teri Marshall
Cartersville, Ga.

Answer: Yes, this is allowable. According to CPT coding guidelines and most payer guidelines, the injection and the drug administered are reported separately. In the above example, 90782 is reported for the administration. Level II HCPCS code J1100 is reported to those payers who recognize this level of codes. For those payers who do not recognize HCPCS codes, 99070 (supplies and materials) can be reported. Because this code is nonspecific, the name of the drug and the dosage administered must be indicated on the claim.

Dexamethosone sodium phosphate is injected intramuscularly to treat acute self-limiting allergic reactions or acute exacerbation of a chronic allergic disorder in an effort to reduce the allergic reaction in the patient.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Primary Care Coding Alert

View All